# Carcinoma, Non-Small-Cell Lung studies: 237 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 237 trials that are observational for Carcinoma, Non-Small-Cell Lung that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Carcinoma, Non-Small-Cell Lung studies: 237 rows for $11.85, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 5 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/carcinoma-non-small-cell-lung

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 237
- Recruiting or not yet: 237
- Read on: November 19, 2026

## Trials

The 25 newest of 237, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07938385 | Characterisation of Immunological and Molecular Changes Evolving in Patients Undergoing Radiotherapy (CHIMERA) | Royal Marsden NHS Foundation Trust | Observational | Recruiting | Impact of the Immune Cell Repertoire on the Therapeutic Index of Radiotherapy, The Need for Serum Markers of... | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938385) |
| November 9, 2026 | NCT07926308 | Real-world Outcome of Zongertinib in Japan (J-HERZ) | Boehringer Ingelheim | Observational | Not yet recruiting | Non-small Cell Lung Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926308) |
| November 6, 2026 | NCT07921888 | Patient-Specific MRD Liquid Biopsy in Resected NSCLC: Plasma and Bronchial Washing ctDNA | Sponsor not shown (see the record) | Observational | Recruiting | Non-Small Cell Lung Cancer, Minimal Residual Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07921888) |
| November 4, 2026 | NCT07914972 | Treatment Pattern and Patient Outcomes Among Stage I-II Unresected NSCLC Patients | AstraZeneca | Observational | Not yet recruiting | Non-small Cell Lung Cancer, NSCLC, Stage I-II Unresected NSCLC | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914972) |
| November 2, 2026 | NCT07911267 | Development and Utilization of an Integrated Clinical Genomic Database | Samsung Medical Center | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer | 118,750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911267) |
| November 2, 2026 | NCT07909343 | Patient Needs and Preferences for NSCL Cancer Treatment Monitoring | European Institute of Oncology | Observational | Recruiting | Lung Cancer (NSCLC) | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909343) |
| October 29, 2026 | NCT07904013 | Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain Metastasis | University Hospital, Bordeaux | Observational | Not yet recruiting | Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Neoplasm Metastasis | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904013) |
| October 28, 2026 | NCT07900581 | Analysis of Whole Exome and Transcriptome Sequencing to Identify Prognostic Biomarkers in Patients With Non-Small Cell Lung Cancer (NSCLC) | Hellenic Cooperative Oncology Group | Observational | Recruiting | Non-small Cell Lung Cancer (NSCLC) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900581) |
| October 19, 2026 | NCT07880106 | Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Observational | Recruiting | Lung Cancer Non-small Cell, Colorectal Cancer, Stomach Cancer, Hepatocellular Carcinoma, Breast Cancer | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880106) |
| October 2, 2026 | NCT07854769 | Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung Cancer | Fox Chase Cancer Center | Observational | Not yet recruiting | Non Small Cell Lung Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07854769) |
| September 25, 2026 | NCT07841249 | Cardiorespiratory Fitness After Lobectomy Versus Sublobar Resection | Tongji Hospital | Observational | Recruiting | Lung Cancer (NSCLC) | 604 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841249) |
| September 23, 2026 | NCT07837739 | Adjuvant EGFR-TKI Therapy After Surgery for EGFR-Mutant High-Risk Stage IA2-IIB NSCLC | Tongji Hospital | Observational | Recruiting | Non-Small Cell Lung Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837739) |
| September 14, 2026 | NCT07817329 | NUT Project: Nutritional Support in Thoracic Oncology | Casa di Cura Dott. Pederzoli | Observational | Recruiting | Oncologic Diseases, Lung Cancer (NSCLC) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817329) |
| September 8, 2026 | NCT07806604 | Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer | Betta Pharmaceuticals Co., Ltd. | Observational | Recruiting | NSCLC (Non-small Cell Lung Cancer) | 2,572 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806604) |
| August 27, 2026 | NCT07790406 | Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer | European Institute of Oncology | Observational | Recruiting | Lung Cancer (NSCLC) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07790406) |
| August 25, 2026 | NCT07783971 | Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance | 958th Army Hospital of the Chinese People's Liberation Army | Observational | Recruiting | Fungal Diseases, Lung Cancer (NSCLC), Microbioata | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783971) |
| August 12, 2026 | NCT07760519 | A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLC | AstraZeneca | Observational | Not yet recruiting | Carcinoma, Non-Small-Cell Lung | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760519) |
| August 10, 2026 | NCT07754409 | Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor. | Göteborg University | Observational | Recruiting | Non-Small Cell Carcinoma of Lung | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754409) |
| August 7, 2026 | NCT07752589 | Microbiota in Neoadjuvant Chemoimmunotherapy for NSCLC | Guangdong Provincial People's Hospital | Observational | Not yet recruiting | Non-Small Cell Carcinoma of Lung, Gut Microbiomes, Neoadjuvant Chemoimmunotherapy | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752589) |
| August 3, 2026 | NCT07743021 | Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data | Center for Molecular Fingerprinting Research Nonprofit LLC | Observational | Recruiting | Non-communicable Diseases (NCD), Neoplams, Cancer, Lung Cancer (NSCLC), Cardiovascular Diseases (CVD), Atherosclerotic... | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743021) |
| August 3, 2026 | NCT07742800 | Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients | Sponsor not shown (see the record) | Observational | Not yet recruiting | Lung Cancer (NSCLC), Lung Cancer (SCLC) | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07742800) |
| July 13, 2026 | NCT07697716 | In Vitro NSCLC EGFR-Mutant Models for Drug Sensitivity Testing | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Carcinoma, Non-Small-Cell Lung, EGFR Gene Mutation | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697716) |
| July 10, 2026 | NCT07696832 | Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or... | Guangdong Association of Clinical Trials | Observational | Recruiting | Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC, EGFR... | 265 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07696832) |
| July 7, 2026 | NCT07686185 | A Non-interventional, Real-world Study on the Adjuvant Treatment of Chinese EGFR-positive Stage IA NSCLC Patients With High-risk Factors... | First Affiliated Hospital of Guangxi Medical University | Observational | Not yet recruiting | Non-Small Cell Lung Cancer, Adjuvant Therapy | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07686185) |
| July 2, 2026 | NCT07680907 | A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm) | Janssen-Cilag Farmaceutica Ltda. | Observational | Not yet recruiting | Carcinoma, Non-Small-Cell Lung | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680907) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 9 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 6 |
| Peking University People's Hospital | 5 |
| Fudan University | 5 |
| Peking University Cancer Hospital & Institute | 4 |
| Shanghai Chest Hospital | 4 |
| European Institute of Oncology | 4 |
| Guangdong Association of Clinical Trials | 3 |
| University of Colorado, Denver | 3 |
| Regina Elena Cancer Institute | 3 |
| Sun Yat-sen University | 3 |
| Henan Cancer Hospital | 3 |
| Ruijin Hospital | 3 |
| Shanghai Pulmonary Hospital, Shanghai, China | 3 |
| National Cancer Institute (NCI) | 3 |
| Samsung Medical Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| Fuzhou General Hospital | 2 |
| Royal Marsden NHS Foundation Trust | 2 |
| Mayo Clinic | 2 |
| OncoHost Ltd. | 2 |
| University Health Network, Toronto | 2 |
| Second Xiangya Hospital of Central South University | 2 |
| Scientific Institute San Raffaele | 2 |

## By country

| Country | Trials |
| --- | --- |
| China | 75 |
| United States | 41 |
| Italy | 27 |
| France | 20 |
| Spain | 10 |
| Germany | 9 |
| Israel | 7 |
| United Kingdom | 7 |
| South Korea | 6 |
| Taiwan | 6 |
| Turkey (Türkiye) | 4 |
| Canada | 4 |
| Austria | 3 |
| Japan | 3 |
| Netherlands | 3 |
| Poland | 2 |
| Belgium | 2 |
| Hungary | 2 |
| Vietnam | 2 |
| Singapore | 2 |
| Greece | 2 |
| Puerto Rico | 2 |
| Czechia | 1 |
| Ukraine | 1 |
| Cyprus | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Publishers in the United States](https://specstream.ai/data/businesses/publishers/united-states)
- [HR services firms in the United States](https://specstream.ai/data/businesses/hr-services-firms/united-states)
- [Cement suppliers in the United States](https://specstream.ai/data/businesses/cement-suppliers/united-states)
- [Threads and yarns wholesalers in the United States](https://specstream.ai/data/businesses/threads-and-yarns-wholesalers/united-states)
- [Middle schools in the United States](https://specstream.ai/data/businesses/middle-schools/united-states)
- [Employment agencies in the United States](https://specstream.ai/data/businesses/employment-agencies/united-states)
